CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers & Opportunities
4.1.1. Increasing demand for cost-effective and non-invasive procedures
4.1.2. Adoption in multi-marker applications with good accuracy
4.1.3. Increasing healthcare expenditure and R&D funding
4.1.4. Increasing the utility of biomarkers for diagnostic purposes
4.2. Market Restraints & Challenges
4.2.1. Complex process and stringent government regulations
4.2.2. Ethical problems and dilemma in the confirmation of results
CHAPTER 5. GLOBAL BIOMARKER TECHNOLOGIES MARKET – BY
TECHNOLOGY
5.1. Omics Technology
5.1.1. Proteomics
5.1.2. Genomics
5.1.3. Transcriptomics
5.2. Imaging technology
5.3. Bioinformatics
CHAPTER 6. GLOBAL BIOMARKER TECHNOLOGIES MARKET – BY
APPLICATION
6.1. Drug discovery
6.2. Diagnostics
6.3. Personalized medicine
CHAPTER 7. GLOBAL BIOMARKER TECHNOLOGIES MARKET – BY DISEASE
APPLICATION
7.1. Cancer
7.2. Diabetes
7.3. Cardiovascular Diseases
7.4. Neurological Disorders
7.5. Infectious Diseases
7.6. Autoimmune Disorders
7.5. Others
CHAPTER 8. GLOBAL BIOMARKER TECHNOLOGIES MARKET - BY
GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9. GLOBAL BIOMARKER TECHNOLOGIES MARKET - COMPANY
PROFILES
9.1. Siemens Healthcare
9.2. Becton, Dickinson and Company
9.3. Bio-Rad Laboratories Inc.
9.4. Agilent Technologies Inc.
9.5. Affymetrix Inc.
9.6. Danaher Corporation
9.7. F. Hoffmann La Roche Ltd.
9.8. Gen-Probe Inc.
9.9. DiagnoCure Inc.
9.10. Abbott Laboratories
CHAPTER 10. GLOBAL BIOMARKER TECHNOLOGIES MARKET COMPETITIVE
LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11. MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12. APPENDIX
12.1. List of Tables
12.2. List of Figures
